Trisilicate

CHEMBL2109882 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

216.3 g/mol

LogP

—

Phase

4

Magnesium trisilicate is an inorganic antacid compound that neutralizes gastric acid by reacting with hydrochloric acid to form magnesium chloride and silicon dioxide, providing symptomatic relief from acid-related disorders. It is used for gastroesophageal reflux disease, peptic ulcers, and dyspepsia, and also acts as an adsorbent that can bind bile acids in the stomach. Its prolonged buffering action and low sodium content make it suitable for long-term antacid therapy.

Masse moléculaire

216,2800 g/mol

TPSA

134,00 Å²

Aires thérapeutiques

Gastroesophageal Reflux Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=[Si](O)O[Si](O)(O)O[Si](=O)O

InChI

InChI=1S/H4O8Si3/c1-9(2)7-11(5,6)8-10(3)4/h1,3,5-6H

Molecular Formula

H4O8Si3

HBD / HBA

4 / 8

Liaisons Rotatives

4

Atomes Lourds

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Magnesium trisilicate is an inorganic antacid compound that neutralizes gastric acid by reacting with hydrochloric acid to form magnesium chloride and silicon dioxide, providing symptomatic relief from acid-related disorders. It is used for gastroesophageal reflux disease, peptic ulcers, and dyspepsia, and also acts as an adsorbent that can bind bile acids in the stomach. Its prolonged buffering action and low sodium content make it suitable for long-term antacid therapy.

Yes, Trisilicate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109882. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5311267. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Trisilicate sur PillFYI

Structure

Données Clés

Formule: H4O8Si3

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.